50 years of experience brought together to lead the medical cannabis future.
Linneo Health is the partner of choice for the pharmaceutical industry. We produce EU-GMP (Good Manufacturing Practices) and GACP (Good Agricultural and Collection Practices) certified medical cannabis and derivatives, integrating in every step the most innovative processes.
The company is supported by 50 years of experience in the agricultural and industrial production of strictly regulated pharmaceutical products. Linneo Health brings together this expertise and experience to contribute to the development of the cannabis industry, ensuring the highest production standards. In this sense, since October 2016, we have the official authorisation to produce cannabis for medical purposes.
In order to accomplish our ambitious expansion plan, we currently have 40,000 m2 of land devoted to the production of cannabis dried flowers. In addition, we have the industrial capacity to process over 12,000 tonnes of biomass per year for the production of extracts and active ingredients derived from cannabis. These capabilities, added to our expertise, position Linneo Health as one of the market leaders and a clear reference in the industry.